INTRODUCTION
Diabetes is one of the most commonly measured diseases in studies of multimorbidity, 1 as well as one of the most frequently detected disorders in multimorbid disease clusters, 2-5 due to its major contribution to the development of heart disease, stroke, kidney failure, non-traumatic lower limb amputations, blindness, and depression. 6 The multimorbidity that typically accompanies diabetes has prompted numerous studies with regard to its prevalence, patterns, and associated health and healthcare outcomes.
Multimorbidity, or the co-existence of multiple chronic diseases in the same individual, is increasingly recognized as a significant global public health challenge. 2, 7, 8 Multimorbidity increases with age, and is associated with a variety of untoward health outcomes, including poor functional status, lower quality of life, higher healthcare utilization, and higher mortality. 2, [9] [10] [11] [12] It is conceptualized not simply as a list of diseases conferring varying degrees of health risk, but as non-randomly occurring clusters of diseases within populations. Moreover, multimorbidity has been shown to vary widely in different settings based on socioeconomic status and race/ethnicity. 13, 14 Racial/ethnic, regional, and rural/urban differences in diabetes control, medication adherence, and mortality are welldocumented among individuals with diabetes. [15] [16] [17] [18] Given the prevalence of comorbid mental health disorders, it is also of particular interest to examine variations in psychiatric versus somatic disorders in patients with diabetes. Mental health disorders, particularly mood spectrum disorders, are strongly linked to worse health outcomes, with higher degrees of overall morbidity, in patients with diabetes. 13, 19 The association of diabetes with physical and psychological problems, and the strength of evidence for significant disparities among veterans with diabetes, warrants further investigation of concurrent physical and mental health conditions that likely contribute to health inequity in this high-risk population. This project was designed to describe patterns of multimorbidity and to measure regional, rural/urban, and racial/ethnic variation in multimorbidity in a large national cohort of patients with type 2 diabetes mellitus. We also present information on multimorbidity grouped by mental versus physical disorders. 20 The NPCD is the source for the VHA Medical SAS data sets used to analyze veteran clinical data such as diagnosis and procedure codes for outpatient visits and inpatient admissions. The PBM database includes utilization information for every prescription filled in the VA, with the Outpatient Pharmacy Package for individual prescriptions dispensed at the site's pharmacy, either as a new fill or a refill. All prescriptions filled by a Consolidated Mail Outpatient Pharmacy are included. The data sets were linked using scrambled patient Social Security numbers.
METHODS

Source of data
Study population
Veterans were followed from time of entry into the study in 2002 through December 2006, loss to follow-up, or until death. The cohort included a total of 892,223 veterans with type 2 diabetes, of which 61.51% were non-Hispanic white, 12.14% were non-Hispanic black, and 13.86% were Hispanic . There were also 12.48% of veterans with either missing or unknown race/ethnicity information. The study was approved by our Institutional Review Board (IRB) and local VA Research and Development committee.
Primary covariates
The primary covariates were race/ethnicity and location of residence. Race/ethnicity was retrieved from the 2002 outpatient and inpatient Medical SAS data sets. When missing or unknown, the variable was supplemented using fields for race from the inpatient 2003 Medical SAS data set, the outpatient 2004 Medical SAS data set, or the VA Vital Status Files from the Centers for Medicare and Medicaid Services. Patient residence was classified as urban or rural; with highly rural categorized as rural as defined by the VA definition of rurality. 21 Other covariates included in the study were age (categorized into four groups: <50, 50-64, 64 22 We also considered medication status (receipt versus non-receipt of prescription for diabetes medication during the study period) and service-connected disability as a dichotomous (<50%, ≥50%) proxy variable to measure copay status, as has been done in multiple prior studies. 17, [23] [24] [25] Outcome measure
The main outcome was multimorbidity, which was operationally defined based on the count of 16 common medical and mental health comorbidities 12, 26 including cancer, cardiovascular disease (CVD), cerebrovascular disease, congestive heart failure, peripheral vascular disease, liver disease, lung disease, fluid and electrolyte disorders, anemia, hypothyroidism, hypertension, obesity, substance abuse (alcohol and drug), psychoses, and depression. Comorbidities were defined based on ICD-9 codes as a history of disease at entry into the cohort, and were dichotomized (present/absent) using a previously validated algorithm. 27 Moreover, to examine comorbidity burden, individuals were grouped by number of comorbidities into the following four groups: 0, 1, 2, and 3+ comorbidities. We also defined a categorical outcome indicating the pattern of multimorbidity defined as medical comorbidity only, mental health comorbidity only, both medical and mental health comorbidities, and no comorbidity (diabetes alone).
Statistical analysis
Poisson regression was used to model the count data (comorbidities), adjusted for covariates. For each covariate, rate ratios and corresponding 95% confidence intervals (CI) were estimated via maximum likelihood using PROC GENMOD in SAS. Similarly, logistic regression was used to model the association between the categorical outcomes and the covariates, and estimates of odds ratios and 95% CI are reported. We examined the count model for overdispersion using the ratio of deviance to degrees-of-freedom and for zero-inflation by comparing models that assume zero-inflation versus no zeroinflation. 28 We did not observe any significant degree of overdispersion or zero-inflation in any of the models, indicating good fit and no excess of zeros (i.e., no comorbidity) in the model. Additionally, we used residual analysis to assess goodness-of-fit for each of the models. All data analyses were conducted using SAS 9.3. (Cary, North Carolina).
RESULTS
The study population comprised 892,223 veterans with diabetes in 2002. The mean number of medical and mental health comorbidities combined was 1.86. Table 1 shows the combined medical and mental health multimorbidity count stratified by demographics, geographic region, residence, serviceconnected disability, and use of any diabetes medication. Comorbidity type is also categorized into patients with diabetes alone and those with medical comorbidity only, mental health comorbidity only, and combined medical and mental health comorbidities, stratified by the same characteristics. The proportion of high-level (3+) multimorbidity increased with increasing age, and was more prevalent in females, nonHispanic blacks, and individuals with ≥50% serviceconnected disability or taking any diabetes medication. Among patients with any comorbidity, the majority (70.2%) had only medical comorbidities, 13.9% had both types of comorbidities, and 1.5% had only mental health comorbidities. Table 2 shows the rate ratio for comorbidity count for the full model (gender, age, race/ethnicity, marital status, geographic region, rural/urban residence, level of serviceconnected disability, and use of diabetes medication). The number of comorbidities, including both medical and mental health, was slightly (5%) higher in women than men, and substantially increased with increasing age. Comorbidity count was 1.11 times higher in non-Hispanic blacks than non-Hispanic whites (95% CI: 1.11, 1.12), but only slightly higher (2%) in Hispanics . Married status appeared to be protective, with a 12% lower rate ratio for comorbidity count compared to unmarried patients. Total comorbidity burden was similar across geographic regions, with rate ratios ranging from 0.98 to 1.02, but higher in rural than urban areas (RR=1.04 [95% CI: 1.04, 1.05]). Patients with ≥50% service-connected disability had 1.26 times the number of comorbidities as those with <50% service-connected disability (95% CI: 1.26, 1.27). Finally, patients not using medication to treat their diabetes had fewer comorbidities than those taking medication (RR=0.83 [95% CI: 0.82, 0.83]). 
DISCUSSION
Among individuals with diabetes, traditionally disadvantaged groups, including non-Hispanic blacks and rural patients, had the greatest burden and risk of multimorbidity. With an increasing number of comorbidities, as well as medical and combined comorbidity types, significantly greater odds were seen with non-Hispanic black race/ethnicity (35-67%), rural residence (7-21%), and Mid-Atlantic, Midwest, and South geographic regions (9-10%). Similar to other studies, older age (77-78% of this cohort 65+ years old) showed the highest odds of medical comorbidity. 8, 14, 27 However, among those with at least 50% service-connected disability, the highest odds of comorbidity type were driven by mental health.
Few studies indicate the co-occurrence of physical and mental health conditions when examining population-based disparities in the veteran population. 5 An important finding by gender showed that women had 8% higher odds of 3+ comorbidities and 16% higher odds of both medical and mental health comorbidities than men. Studies have also shown greater CVD risk burden 29 and mental health disorders in women, 30 who represent a growing population of veterans. The significantly lower multimorbidity among married veterans resonates with other studies showing this finding as an important support mechanism for male versus female veterans. 31 Prior studies of racial/ethnic, regional, and rural/urban differences in diabetes outcomes [14] [15] [16] [17] [18] demonstrated a twofold higher potential for physical multimorbidity in non-Hispanic black patients due to poorer control of CVD risk factors and a lower rate of medication adherence. This study found that non-Hispanic black patients had 25-67% greater risk of medical, mental health, and combined comorbidities. The synergistic effect of the greater number of medical and mental health comorbidities present in more disadvantaged populations is a contributing factor to the gap in health equity evidenced in the literature.
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The prevalence of coexisting medical and mental health conditions is clear among disadvantaged populations, with a convincing base of evidence. One study in a Scottish population (1.75 million) found that individuals in the most socioeconomically deprived areas had 10-15 years' earlier onset of multimorbidity and 11-fold higher odds of both physical and mental health disorders than their wealthier counterparts. Medical and mental health multimorbidity also increases likely utilization of healthcare, with two-and fivefold greater odds, respectively, of unplanned hospitalization. 12 These findings necessitate the development of interventions that use a multifaceted approach in patients with multimorbidity in order to improve equity in health and healthcare, which will likely be facilitated through health information technology. 32 It is clear from this analysis that location of residence is also both a statistically and clinically important factor as a measure of health, and can be a powerful predictor of health outcomes and disparities. Rural veterans were more likely to have 3+ comorbidities (OR 1.21). They were also more likely to have medical only, mental health only, or both comorbidity types than those living in urban areas. Recent studies conducted to improve health services utilization through an understanding of predictors of poor uptake for invited diabetes screening found that those deemed socioeconomically deprived 33, 34 were approximately 20% more likely not to participate, and that lack of participation was threefold greater for younger people. 34 Interventions that use telemonitoring combined with another supportive strategy (such as active case management or care coordination) to improve glycemic control show higher potential for sustained post-intervention effect. [35] [36] [37] [38] While there has been a growing number of such behavioral randomized trials or comprehensive multifaceted interventions, few have presented longitudinal outcomes data for improved health equity in disadvantaged populations with type 2 diabetes. Collectively, such studies will lead toward a better understanding of some of the root causes and variations of health equity, as well as potential interventions for improving equity in healthcare across different populations. The challenge inherent in achieving parity in care is in devising effective strategies that effect more coordinated multifaceted management of clinical care, while simultaneously addressing social elements in the context of limited resources so that the unseen daily management occurs at the same level of intensity.
There are important advantages in showing the pattern of multimorbidity in a very large population of patients who have similar access to healthcare, such as in the VA healthcare system. The paradigm shift in the focus of care toward patients rather than their disease, combined with provisions from the Affordable Care Act that increase access to healthcare across the broader U.S. population, should enhance the ability of various healthcare systems to improve the management of multimorbidity. However, the shifting demographic toward racial/ethnic minorities who bear a heavier burden and higher risk of chronic disease, with poorer control, calls for greater focus on comprehensive patient-focused interventions that empower patients for greater self-management. These study findings must be applied in the appropriate context. This study is limited by a lack of information on disease severity, chronological development of comorbid conditions, and clusters (combinations) of chronic conditions in specific demographic groups. 39 Another limitation is generalizability to the larger U.S. population with diabetes. However, our findings can be generalized to older adults in large healthcare systems such as the Geisinger Health System, Group Health, or Kaiser Permanente. Similarly, while the proportion of women in our study is relatively low, the absolute number of women and greater multimorbidity among them 13 strongly indicates the need for further investigation of gender differences.
These findings provide better characterization of disparities in multimorbidity patterns, information that can be used by frontline clinicians to assist with coordinated management of diabetes. As an increasing number of studies examine shared etiologies and risk factors for disease clusters, clinical services and health policies must set targets toward management efforts that shape guidelines for best practices in multimorbidity, 39 but also cannot ignore patient-specific needs. This study will also aid in understanding patterns of multimorbidity in a way that facilitates planning and coordination of health services to align well with the needs of diverse groups of individuals with diabetes and heavy comorbidity burden. Beyond the recognition of distribution of chronic diseases (e.g., co-occurring diabetes, hypertension, stroke, obesity, and depression), the development and execution of a multifaceted, culturally congruent approach to managing chronic disease clusters is most likely to have a powerful impact on patient care and health outcomes for individuals with diabetes. 
